Weather in Kaunas

Time in

Vilnius, Tallinn, Riga

www.ema.europa.eu

Syndicate content
Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products
URL: http://www.ema.europa.eu
Updated: 13 hours 42 min ago

Human medicines European Public Assessment Report (EPAR): Xigris, drotrecogin alfa (activated), Revision: 13, Withdrawn

Tue, 02/21/2012 - 02:00
Categories: Category 1

Human medicines European Public Assessment Report (EPAR): Zavesca, miglustat, Revision: 17, Authorised

Mon, 02/20/2012 - 18:38
Categories: Category 1

Human medicines European Public Assessment Report (EPAR): Zavesca, miglustat, Revision: 17, Authorised

Mon, 02/20/2012 - 18:38
Categories: Category 1

Human medicines European Public Assessment Report (EPAR): Synflorix, pneumococcal polysaccharide conjugate vaccine (adsorbed), Revision: 5, Authorised

Mon, 02/20/2012 - 18:35
Categories: Category 1

Human medicines European Public Assessment Report (EPAR): Synflorix, pneumococcal polysaccharide conjugate vaccine (adsorbed), Revision: 5, Authorised

Mon, 02/20/2012 - 18:35
Categories: Category 1

Human medicines European Public Assessment Report (EPAR): Erbitux, cetuximab, Revision: 17, Authorised

Mon, 02/20/2012 - 17:07
Categories: Category 1

Human medicines European Public Assessment Report (EPAR): Erbitux, cetuximab, Revision: 17, Authorised

Mon, 02/20/2012 - 17:07
Categories: Category 1

Human medicines European Public Assessment Report (EPAR): Rivastigmine Hexal, rivastigmine, Revision: 3, Authorised

Fri, 02/17/2012 - 17:50
Categories: Category 1

Human medicines European Public Assessment Report (EPAR): Rivastigmine Hexal, rivastigmine, Revision: 3, Authorised

Fri, 02/17/2012 - 17:50
Categories: Category 1

Human medicines European Public Assessment Report (EPAR): Resolor, prucalopride, Revision: 5, Authorised

Fri, 02/17/2012 - 10:58
Categories: Category 1

Human medicines European Public Assessment Report (EPAR): Resolor, prucalopride, Revision: 5, Authorised

Fri, 02/17/2012 - 10:58
Categories: Category 1

Pending EC decision: Sabervel, irbesartan, Opinion date: 16-Feb-2012

Fri, 02/17/2012 - 02:00
Categories: Category 1

Pending EC decision: Sancuso, granisetron, Opinion date: 16-Feb-2012

Fri, 02/17/2012 - 02:00
Categories: Category 1

Pending EC decision: PegIntron, peginterferon alfa-2b, Opinion date: 16-Feb-2012

Fri, 02/17/2012 - 02:00
Categories: Category 1

Pending EC decision: Capecitabine Teva, capecitabine, Opinion date: 16-Feb-2012

Fri, 02/17/2012 - 02:00
Categories: Category 1

Pending EC decision: Nimenrix, Neisseria meningitidis serogroups, Opinion date: 16-Feb-2012

Fri, 02/17/2012 - 02:00
Categories: Category 1

Pending EC decision: Humira, adalimumab, Opinion date: 16-Feb-2012

Fri, 02/17/2012 - 02:00
Categories: Category 1

Pending EC decision: Byetta, exenatide, Opinion date: 16-Feb-2012

Fri, 02/17/2012 - 02:00
Categories: Category 1

Pending EC decision: Votrient, pazopanib, Opinion date: 16-Feb-2012

Fri, 02/17/2012 - 02:00
Categories: Category 1

Pending EC decision: Rebetol, ribavirin, Opinion date: 16-Feb-2012

Fri, 02/17/2012 - 02:00
Categories: Category 1
  • Professionalism.
    We are specialists in this field and like our activity, so we can guarantee the quality of our work.
  • Competitiveness.
    Individual solutions for a competitive price.
  • Confidentiality.
    We appreciate the cooperation, maintain confidentiality and seek for a long-term partnership
 

My status

Member of Medicines Manufacturers Association